Clinical Trial Registration Policy

1.1 Registration Requirements

All clinical trials submitted to GSHH must:

• Be registered in WHO-approved primary registries (e.g., ClinicalTrials.gov, ANZCTR, PACTR, CTRI/ICMR, Pan African Clinical Trials Registry)
• Include registration before the first participant enrollment (prospective registration)
• Provide the registration number and registry name in the manuscript's Methods section
• Report all primary and secondary outcomes specified in the registry

1.2 Acceptable Registries

GSHH recognises:

• WHO International Clinical Trials Registry Platform (ICTRP) primary registries
• Regional registries serving the Global South (e.g., PACTR, CTRI)
• NIH ClinicalTrials.gov
• ISRCTN registry

1.3 Exceptions

Registration may be waived for:

• Pilot/feasibility studies (<50 participants)
• Observational studies without intervention
• Case reports/series

Contact

For queries:
team.gshh@cecr.com.ng
+234-806-195-6031

Policy Effective Date: [30/04/2025]
Next Review Date: [29/04/2030]